Tiens Biotech Group (USA) Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
66.81 Mil |
| Income |
25.89 Mil |
| Net Profit Margin |
40.99% |
| Return on Equity |
16.48% |
| Debt/Equity Ratio |
0.02 |
|
| Revenue/Share |
0.94 |
| Earnings/Share |
0.36 |
| Book Value/Share |
2.39 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 18.2 | 12.8 | 16.2 |
| 2nd Qtr | 20.6 | 19.7 | 14.3 |
| 3rd Qtr | 9.4 | 26.2 | 11.0 |
| 4th Qtr | NA | 18.6 | 13.3 |
| Total | 48.2 | 77.2 | 54.9 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.12 | $0.05 | $0.09 |
| 2nd Qtr | $0.14 | $0.07 | $0.07 |
| 3rd Qtr | $0.03 | $0.20 | $0.04 |
| 4th Qtr | NA | $0.07 | $0.05 |
| Total | $0.29 | $0.39 | $0.25 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 71% | 0% | --- |
| 2nd Qtr | 17% | 40% | -22% |
| 3rd Qtr | -79% | 186% | -43% |
| 4th Qtr | NA | -65% | 25% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 140% | -44% |
| 2nd Qtr | 100% | 0% |
| 3rd Qtr | -85% | 400% |
| 4th Qtr | NA | 40% |
advertisement
Recent News